BSX vs. CVS: Boston Scientific vs. CVS Health Stock Comparison
How do Boston Scientific (BSX) and CVS Health (CVS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and CVS Health (CVS) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while CVS is classified in Health Care Providers & Services.
| Profile Item | BSX | CVS |
|---|---|---|
| Name | Boston Scientific Corp. | CVS Health Corporation Common Stock |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 61.96 billion USD | 107.28 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | February 21, 1973 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | CVS |
|---|---|---|
| Total Return (1Y) | -55.98% | 11.41% |
| Total Return (3Y, Annualized) | -5.05% | 12.73% |
| Total Return (5Y, Annualized) | 0.57% | 1.70% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | CVS |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 34.14% |
| Beta (5Y) | 0.57 | 0.60 |
| Max Drawdown (5Y) | -61.55% | -56.79% |
| Avg. Volume (3M) | 19.73M | 8.60M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | CVS |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 0.21 |
| Sortino Ratio (1Y) | -1.80 | 0.28 |
Profitability
ROE (TTM)
Both Boston Scientific (BSX) at 14.12% and CVS Health (CVS) at 14.36% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
CVS
Health Care Equipment & Services industry group
14.36%
- Max
- 47.61%
- CVS
- 14.36%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of CVS Health (CVS) at 2.64%, which keeps about the industry-typical share.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
CVS
Health Care Equipment & Services industry group
2.64%
- Max
- 29.35%
- Q3
- 9.33%
- CVS
- 2.64%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of CVS Health (CVS) at 2.72%, which runs around its industry’s norm.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
CVS
Health Care Equipment & Services industry group
2.72%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CVS
- 2.72%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | CVS |
|---|---|---|
| ROE (TTM) | 14.12% | 14.36% |
| ROA (TTM) | 5.87% | 3.11% |
| Net Margin (TTM) | 16.62% | 2.64% |
| Operating Margin (TTM) | 19.05% | 2.72% |
| Gross Margin (TTM) | 67.98% | 13.72% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and CVS Health (CVS) at 7.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while CVS Health (CVS) at -62.02% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | BSX | CVS |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 7.85% |
| Revenue Growth (3Y CAGR) | 16.54% | 7.63% |
| EPS Growth (YoY) | 55.20% | -62.02% |
| EPS Growth (3Y CAGR) | 62.75% | -24.73% |
Financial Strength
Current Ratio (MRQ)
Both Boston Scientific (BSX) at 1.37 and CVS Health (CVS) at 0.85 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
CVS
Health Care Equipment & Services industry group
0.85
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CVS
- 0.85
- Min
- 0.30
Debt / Equity (MRQ)
Boston Scientific (BSX) at 0.46 carries an industry-typical debt-to-equity mix, while CVS Health (CVS) at 0.93 uses more debt funding than most peers.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
CVS
Health Care Equipment & Services industry group
0.93
- Max
- 1.88
- CVS
- 0.93
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | CVS |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 0.85 |
| Debt / Equity (MRQ) | 0.46 | 0.93 |
| Net Debt / EBITDA | 2.04 | 3.49 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 3.27%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CVS
Health Care Equipment & Services industry group
3.27%
- CVS
- 3.27%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 30.89%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CVS
Health Care Equipment & Services industry group
30.89%
- CVS
- 30.89%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | CVS |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 3.27% |
| Dividend Payout Ratio (TTM) | 0.00% | 30.89% |
Valuation
P/E Ratio (TTM)
Both Boston Scientific (BSX) at 18.04 and CVS Health (CVS) at 9.74 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
CVS
Health Care Equipment & Services industry group
9.74
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CVS
- 9.74
- Min
- 4.21
P/S Ratio (TTM)
CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
CVS
Health Care Equipment & Services industry group
0.26
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CVS
- 0.26
- Min
- 0.03
P/B Ratio (MRQ)
CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile against book while Boston Scientific (BSX) at 2.42 is valued near its industry’s middle — CVS is cheaper on assets, though weigh it against ROE and asset quality.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
CVS
Health Care Equipment & Services industry group
1.33
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- CVS
- 1.33
- Min
- -1.31
Valuation Metrics
| Metric | BSX | CVS |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 9.74 |
| P/S Ratio (TTM) | 2.94 | 0.26 |
| P/B Ratio (MRQ) | 2.42 | 1.33 |
| Free Cash Flow Yield (TTM) | 4.02% | 11.02% |